Evidence supporting the use of: Resveratrol analog (unspecified)
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol analogs are being investigated for their potential to support or treat osteoporosis, primarily due to their biological activities observed in preclinical studies. Resveratrol is a polyphenolic compound found in grapes and other plants, and its analogs are chemically modified derivatives designed to improve stability or bioavailability. In animal models and in vitro studies, resveratrol and some analogs have demonstrated osteoprotective effects, such as promoting osteoblast differentiation (bone formation), inhibiting osteoclast activity (bone resorption), and modulating signaling pathways like SIRT1 and RANKL/OPG that are involved in bone metabolism.

However, there is a lack of robust clinical evidence in humans to support the use of resveratrol analogs for osteoporosis. Most data come from laboratory or animal studies, and limited human trials have not established clear efficacy or optimal dosing. Systematic reviews and meta-analyses, as of 2024, generally conclude that while resveratrol exhibits promise in experimental settings, more high-quality clinical research is needed before recommending its analogs for osteoporosis prevention or treatment. Thus, the evidence supporting their use is preliminary and rated as low to moderate (2/5).

References:

  • Vester H, et al. "Resveratrol and its analogs: Potent agents for osteoporosis prevention and treatment?" Phytomedicine, 2022.
  • Guo R, et al. "Potential therapeutic action of resveratrol in bone loss: Preclinical evidence and molecular mechanisms." Current Pharmaceutical Design, 2021.

More about Resveratrol analog (unspecified)
More about Osteoporosis

Products containing Resveratrol analog (unspecified)

We currently have no products on Vitabase that contain this ingredient.